What's in Store for ADMA Biologics (ADMA) in Q1 Earnings? [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
Let's see how things have shaped up for the quarter to be reported. Factors at Play ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. The company's top line currently comprises sales of three FDA-approved products, namely – Bivigam (to treat primary humoral immunodeficiency), Asceniv (to treat primary immunodeficiency) and Nabi-HB (to treat and provide enhanced immunity against the hepatitis B virus). Revenues in the last reported quarter jumped around 48% year over year owing to strong sales of its immunoglobulin products, a trend mostly likely to have continued in the to-be-reported quarter. The company's commercial specialty biologics product portfolio has been witnessing exponential growth and the momentum is likely to have continued in the to-be-reported quarter. Shares of ADMA have rallied 44.9% so far this year against the industry's decline of 10.4%. Image Source: Zacks Inves
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- 5 Stocks With Recent Price Strength to Tap May's Rally [Yahoo! Finance]Yahoo! Finance
- Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? [Yahoo! Finance]Yahoo! Finance
- Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMSPR Newswire
- Giving ADMA Biologics A Well-Deserved 'Booyah' [Seeking Alpha]Seeking Alpha
- ADMA Biologics First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
ADMA
Earnings
- 5/9/24 - Beat
ADMA
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/15/24 - Form ARS
- ADMA's page on the SEC website